Mark Eisner

2021

In 2021, Mark Eisner earned a total compensation of $3.8M as Chief Medical Officer at FibroGen, a 4% decrease compared to previous year.

Compensation breakdown

Bonus$1,000,000
Non-Equity Incentive Plan$218,100
Option Awards$1,157,212
Salary$600,000
Stock Awards$739,984
Other$52,310
Total$3,767,606

Eisner received $1.2M in option awards, accounting for 31% of the total pay in 2021.

Eisner also received $1M in bonus, $218.1K in non-equity incentive plan, $600K in salary, $740K in stock awards and $52.3K in other compensation.

Rankings

In 2021, Mark Eisner's compensation ranked 3,542nd out of 12,415 executives tracked by ExecPay. In other words, Eisner earned more than 71.5% of executives.

ClassificationRankingPercentile
All
3,542
out of 12,415
72nd
Division
Manufacturing
1,451
out of 5,501
74th
Major group
Chemicals And Allied Products
587
out of 2,374
75th
Industry group
Drugs
524
out of 2,095
75th
Industry
Pharmaceutical Preparations
366
out of 1,542
76th

Pay ratio

Mark Eisner's Pay$3,767,606
Median Employee's Pay$174,414
Pay Ratio

22

to 1

In 2021, the annual total compensation of Mark Eisner was $3,767,606.

The annual total compensation of the median employee at FibroGen was $174,414.

The ratio of Mark Eisner's pay to the pay of median employee was therefore 22 to one.

Source: SEC filing on April 28, 2022.

Eisner's colleagues

We found six more compensation records of executives who worked with Mark Eisner at FibroGen in 2021.

2021

Enrique Conterno

FibroGen

Chief Executive Officer

2021

Christine Chung

FibroGen

Senior Vice President, China Operations

2021

Pat Cotroneo

FibroGen

Chief Financial Officer

2021

Elias Kouchakji

FibroGen

Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance

2021

Thane Wettig

FibroGen

Chief Commercial Officer

2021

Juan Graham

FibroGen

Chief Financial Officer

News

You may also like